跳至主要内容
临床试验/EUCTR2013-003268-29-IT
EUCTR2013-003268-29-IT进行中(未招募)不适用

Hyperbaric oxygen therapy in the treatment of sudden hydiopatic sensorineural hearing loss - Hyperbaric oxygen therapy in sudden SNH

AUSL Piacenza0 个研究点开始时间: 2013年8月27日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -age > 18 yrs
  • -unilateral sensorineural hearing loss appeared in less than 72 hrs
  • -hearing threshold equal or greater than 30 dB at three or more adjacent frequencies
  • -therapy starting maximum 7 days after the symptoms appearance
  • -signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 160
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 80

排除标准

  • -Middle ear disease
  • -Previous sudden hearing loss (relapsing hearing loss)
  • -Definite diagnosis (definite viral infection, Meniere’s disease, acoustic neuroma, ototoxyc drugs, multiple sclerosys)
  • -High embolic risk from cardiac or vascular diseases
  • -HOT contraindications (pneumotorax, upper respiratory tract infections, seizures, chemotherapy, psycosis)
  • -Gastric ulcer
  • -Pregnancy
  • -No informed consent

研究者

发起方
AUSL Piacenza

相似试验